Spots Global Cancer Trial Database for battle program
Every month we try and update this database with for battle program cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC | NCT00410189 | Lung Cancer | ZD6474 | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC | NCT00410059 | Lung Cancer | Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: Sorafenib in Patients With NSCLC | NCT00411671 | Lung Cancer | Sorafenib | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00411632 | Lung Cancer | Bexarotene Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC | NCT00410059 | Lung Cancer | Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC | NCT00410189 | Lung Cancer | ZD6474 | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC) | NCT00409968 | Lung Cancer | Tumor Biopsy | 18 Years - | M.D. Anderson Cancer Center | |
BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC | NCT00410189 | Lung Cancer | ZD6474 | 18 Years - | M.D. Anderson Cancer Center |